ArticleJournal of chemical information and modeling2026
Enabling Automatic Generation of Protein-Ligand Complex Data Sets with Atomistic Detail.
Article in Journal of chemical information and modeling, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Enabling Automatic Generation of Protein-Ligand Complex Data Sets with Atomistic Detail.Journal of chemical information and modeling · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Predicting protein-ligand bioactivities is known to be challenging yet crucial in any drug discovery project. In a protein structure-based scenario, supervised machine-learning models have been highly competitive for at least 30 years. Regardless of the machine-learning method used, data set size and quality are key aspects in model training and validation. In general, data sets are the foundation upon which accurate performance estimates can be obtained. While well-curated repositories exist for bioactivity and protein structure data, combining these two types of data is particularly challenging. With ActivityFinder, we recently introduced a fully automated process for linking these data sources relying on protein sequence and molecular structure only. By combining ActivityFinder with previously developed tools for structure quality estimation and property calculation, we created StrAcTable, an automatically constructed data set of annotated protein-ligand complexes. The automated procedure allows for continued and sustainable growth. StrAcTable includes detailed descriptions of the quality of matching between ChEMBL and PDB, of the macromolecular structure, small-molecule ligands bound, and bioactivity data from ChEMBL. Based on ChEMBL Version 35, the StrAcTable contains 20,063 protein-ligand complexes with bioactivity values, enabling an efficient construction of training and validation data sets for structure-based molecular design method development. With that, StrAcTable aims to be the basis for novel data sets that can be used to train and test ML and traditional methods.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.